These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 7372555)

  • 41. Ceforanide. A review of its antibacterial activity, pharmacokinetic properties and clinical efficacy.
    Campoli-Richards DM; Lackner TE; Monk JP
    Drugs; 1987 Oct; 34(4):411-37. PubMed ID: 3315624
    [TBL] [Abstract][Full Text] [Related]  

  • 42. SK&F 75073, new parenteral broad-spectrum cephalosporin with high and prolonged serum levels.
    Actor P; Uri JV; Zajac I; Guarini JR; Phillips L; Pitkin DH; Berges DA; Dunn GL; Hoover JR; Weisbach JA
    Antimicrob Agents Chemother; 1978 May; 13(5):784-90. PubMed ID: 96734
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Comparative evaluation of cefamandole and cephalothin in the treatment of experimental Staphylococcus aureus osteomyelitis in rabbits.
    Mader JT; Wilson KJ
    J Bone Joint Surg Am; 1983 Apr; 65(4):507-13. PubMed ID: 6833327
    [No Abstract]   [Full Text] [Related]  

  • 44. [In-vitro activity of cefonicid on hospital bacteria. Regression line and proposal for critical values].
    Chanal M; Cluzel M; Sirot D; Joly B; Sirot J; Cluzel R
    Pathol Biol (Paris); 1986 May; 34(5):385-9. PubMed ID: 3095773
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Comparative activity of two newer cephalosporins, cefoxitin, and cephalothin against selected Enterobacteriaceae and correlation with enzymatic resistance mechanisms.
    Vuye A; Pijck J; Van Landuyt HW
    J Antimicrob Chemother; 1979 May; 5(3):293-300. PubMed ID: 314440
    [No Abstract]   [Full Text] [Related]  

  • 46. Antistaphylococcal activity of ceforanide and cefonicid in the presence of human serum.
    Barry AL; Jones RN; Packer RR
    Antimicrob Agents Chemother; 1986 Jan; 29(1):147-9. PubMed ID: 3729326
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Update on drug therapy. IV. Parenteral cephalosporins.
    Dahl SL; Elenbaas J; Hamburger S
    J Am Med Womens Assoc (1972); 1980 Apr; 35(4):99-100, 107-8. PubMed ID: 6246160
    [No Abstract]   [Full Text] [Related]  

  • 48. [Cefoxitin, a new beta-lactamase stable antibiotic].
    Simon C; Meyer E; Malerczyk
    Arzneimittelforschung; 1978; 28(9):1541-5. PubMed ID: 314296
    [No Abstract]   [Full Text] [Related]  

  • 49. The activity of cephalosporins on beta-lactamase-producing Neisseria gonorrhoeae.
    Phillips I; Shannon K
    Scand J Infect Dis Suppl; 1978; (13):23-6. PubMed ID: 98833
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Reassessment of the "class" concept of disk susceptibility testing. Cephalothin disks versus minimal inhibitory concentrations with eleven cephalosporins.
    Barry AL; Thornsberry C; Jones RN; Fuchs PC; Gavan TL; Gerlach EH
    Am J Clin Pathol; 1978 Dec; 70(6):909-13. PubMed ID: 727174
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Effect of cephalosporins on bilirubin-albumin binding.
    Robertson A; Fink S; Karp W
    J Pediatr; 1988 Feb; 112(2):291-4. PubMed ID: 3339510
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Synergistic enhancement of in vitro antimicrobial activity of imipenem and cefazolin, cephalothin, cefotiam, cefamandole or cefoperazone in combination against methicillin-sensitive and -resistant Staphylococcus aureus.
    Uete T; Matsuo K
    Jpn J Antibiot; 1995 Mar; 48(3):402-8. PubMed ID: 7752453
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Reliability of cefaclor, cefazolin, cefamandole, and cephalothin disks to predict susceptibility of Enterobacteriaceae, Staphylococcus species, and Haemophilus influenzae.
    Barry AL; Jones RN; Thornsberry C
    Am J Clin Pathol; 1985 Nov; 84(5):643-8. PubMed ID: 3877452
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Effect of hydrogen ion and protein concentrations on the activity of beta-lactam antibiotics.
    Platt R; Rosner B
    Rev Infect Dis; 1984; 6 Suppl 4():S829-34. PubMed ID: 6522925
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A comparison of the in vitro activity of a new cephalosporin, cefuroxime, and cephalothin against 810 clinical isolates.
    Skar AG; Midtvedt T; Dahl O
    NIPH Ann; 1979 Dec; 2(2):31-40. PubMed ID: 398460
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Affinity of cefonicid, a long-acting cephalosporin, for the penicillin-binding proteins of Escherichia coli K-12.
    Rake JB; Newman DJ; Actor P
    J Antibiot (Tokyo); 1984 May; 37(5):572-6. PubMed ID: 6376452
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Cefonicid. A review of its antibacterial activity, pharmacological properties and therapeutic use.
    Saltiel E; Brogden RN
    Drugs; 1986 Sep; 32(3):222-59. PubMed ID: 3530703
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Determination of in vitro susceptibility of Mycobacterium tuberculosis to cephalosporins by radiometric and conventional methods.
    Heifets LB; Iseman MD; Cook JL; Lindholm-Levy PJ; Drupa I
    Antimicrob Agents Chemother; 1985 Jan; 27(1):11-5. PubMed ID: 3920957
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Effectivity of cephazoline and cephadrine in comparison with cephalothin].
    Toeller W; Simon C
    Med Welt; 1973 Sep; 24(37):1411-2. PubMed ID: 4766303
    [No Abstract]   [Full Text] [Related]  

  • 60. Comparative bactericidal effect of ceforanide (BL-S 786) and five other cephalosporins in an in vitro pharmacokinetic model.
    Randolph JA; Buck RE; Price KE; Leitner F
    J Antibiot (Tokyo); 1979 Jul; 32(7):727-33. PubMed ID: 396292
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.